Astria Corp (ATXS) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
Astria Therapeutics (ATXS) uchun ushbu bozor baholash grafigi 0.01 miqdorida baholangan aktivning narx harakatini aks ettiradi. Astria Therapeutics immun patologiyalari uchun davolash usullarini sinovdan o'tkazish maqsadida tadqiqot markazlari bilan hamkorlik qilmoqda. Korxona hozirda kam uchraydigan kasalliklar uchun terapiya vositalarini ishlab chiqishga e'tibor qaratgan bo'lib, litsenziyalar olingandan keyin daromad olishni kutmoqda, pudratchilarning diversifikatsiyasi esa tibbiy testlar uchun komponentlarning uzluksiz yetkazib berilishini ta'minlaydi.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_ATXS_-_Astria-Therapeutics_-_Long-Term-Debt-to-Capital "ATXS: Astria Therapeutics, Inc. Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 07.02.2026 | 👁️GURU.Markets👁️")
Astria Therapeutics (ATXS) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Astria Therapeutics|ATXS - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati astriatx.com|ATXS - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Astria Therapeutics, Inc.|ATXS - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Astria Therapeutics|Tezkor likvidlik ko‘rsatkichi astriatx.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:Astria Therapeutics Inc - ATXS
Katta miqyosdagi birlashmalarsiz, faqat bitta kamyob kasalliklar dori vositasini ishlab chiqishga e'tibor qaratish orqali Astria Therapeutics (ATXS) o'zining qarz yukini minimallashtiradi. Uzoq muddatli qarz kapitali va o'z kapitali o'rtasidagi nisbat tahlili kompaniyaning muddati bir yildan ortiq bo'lgan tashqi kreditlarga bog'liqligini baholash imkonini beradi, bu esa balansning barqarorligini va biznesning pul oqimi uzilishlari xavfisiz, o'z kapitali hisobidan klinik sinovlarni moliyalashtirish qobiliyatini belgilaydi.
Muhim raqobatchilar
argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Pharvaris Pharma (PHVS)|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|tourmalinebio.com (TRML) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Precigen (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|Uzoq muddatli qarzning o'z kapitaliga nisbati NKTR|Uzoq muddatli qarzning kapitalga nisbati Upstream Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc (ZBIO)|immunome.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Septerna Corp - Uzoq muddatli qarzning kapitalga nisbati|PVLA - Uzoq muddatli qarzning kapitalga nisbati|Savara Inc. (SVRA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|RIGL - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ANAB|ENGN (enGene Holdings Inc) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati RAPT Therapeutics, Inc. (RAPT)|JBIO (aerovatetx.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ACRS (Aclaris Therapeutics)|Uzoq muddatli qarzdorlikning kapitalga nisbati kyvernatx.com (KYTX)|Tiziana Life Sciences Ltd - Uzoq muddatli qarzning kapitalga nisbati|CABA - Uzoq muddatli qarzning kapitalga nisbati|VTYX (Ventyx Bio) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Theratechnologies, Inc - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati AVTX|ELDN (eledon.com) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati AGEN|CLYM (Climb Bio Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ZURA (Zura Bio Limited)|aTyr Pharmaceuticals (ATYR) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ADAG - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti IMA (ImageneBio Inc)|STTK: Uzoq muddatli qarzning kapitalga nisbati|Equillium (EQ) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Connect Biopharma Holdings|Immunic Inc - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ATRA|IFRX - Uzoq muddatli majburiyatlarning kapitalga nisbati|X4 Pharmaceuticals, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Adicet Bio Inc. ACET|CELU: Uzoq muddatli qarzning o'z kapitaliga nisbati|INmune Bio Corporation - Uzoq muddatli kreditlarning kapitalga nisbati|BRNS: Uzoq muddatli qarzning kapitalga nisbati|KZR - Uzoq muddatli qarzdorlikning kapitalga nisbati|SABS (SAB Biotherapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Akari Therapeutics PLC (AKTX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Enlivex Therapeutics (ENLV)|Uzoq muddatli qarzdorlikning kapitalga nisbati q32bio.com|Uzoq muddatli qarzning kapitalga nisbati GOVX (GeoVax Labs, Inc.)|Uzoq muddatli qarzning kapitalga nisbati edesabiotech.com EDSA|IBIO: Uzoq muddatli qarzning o'z kapitaliga nisbati|Carisma Therapeutics - Uzoq muddatli kreditlarning kapitalga nisbati|XTLB (XTL Biopharmaceuticals, Ltd.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BOLT|Uzoq muddatli qarzning o'z kapitaliga nisbati HCW Biologics, Inc.|Aptevo (APVO) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati AIM ImmunoTech (AIM)|ADTX: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati GRI (GRI Bio Corp)|Uzoq muddatli qarzning kapitalga koeffitsiyenti XRTX|Vyome Holdings Inc - Uzoq muddatli qarzning kapitalga nisbati|REVB - Uzoq muddatli qarzning kapitalga nisbati|Indaptus Therapeutics, Inc. (INDP) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Scinai Immunotherapeutics Ltd - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati CalciMedica Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati Affimed Therapeutics (AFMD)|Uzoq muddatli qarzning kapitalga nisbati ALLK|Uzoq muddatli qarzning kapitalga nisbati hookipapharma.com (HOOK)|IGM Biosciences - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ITOS|Ocean Bio - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati TC BioPharm Ltd TCBP|Third Harmonic Bio (THRD) - Uzoq muddatli qarzning o'z kapitaliga nisbati